Loading…
Loading grant details…
| Funder | NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE |
|---|---|
| Recipient Organization | Washington University |
| Country | United States |
| Start Date | Feb 01, 2021 |
| End Date | Sep 12, 2023 |
| Duration | 953 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10545020 |
Abstract Chronic itch is an unmet medical problem associated with numerous skin, immune, and nervous diseases. An imbalance of excitatory and inhibitory transmission of itch may contribute to the etiology of chronic itch. Understanding of inhibitory mechanisms of itch transmission is important for developing targeted anti-itch
therapies. The spinal cord interneurons expressing gastrin-releasing peptide receptor (GRPR) are crucial for itch transmission. Recent studies suggest that a subset of inhibitory neurons expressing neurokinin 3 receptor (TacR3) may be activated by pain for itch inhibition. We will employ an interdisciplinary approach to test the
hypothesis that TacR3 inhibitory neurons inhibit itch but not pain by inhibiting GRPR neurons. Aim 1 will determine anatomic and electrophysiological properties of TacR3 inhibitory neurons. Aim 2 will determine the role of spinal TacR3 inhibitory neurons in itch inhibition. Aim 3 will determine whether TacR3 neurons inhibit
GRPR neurons via GABAergic transmission. These studies should yield fundamental insight onto the spinal mechanisms by which itch is inhibited by pain.
Washington University
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant